|
DERA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.70980000011734E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.14559999953823E-07 |
| Normal-vs-Stage2 |
8.251800E-01 |
| Normal-vs-Stage3 |
2.0734999999994E-05 |
| Normal-vs-Stage4 |
1.597150E-03 |
| Stage1-vs-Stage2 |
2.539800E-03 |
| Stage1-vs-Stage3 |
6.464000E-01 |
| Stage1-vs-Stage4 |
6.131000E-01 |
| Stage2-vs-Stage3 |
2.363000E-03 |
| Stage2-vs-Stage4 |
1.679870E-02 |
| Stage3-vs-Stage4 |
4.285200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.17140000044769E-07 |
| Normal-vs-AfricanAmerican |
1.138780E-03 |
| Normal-vs-Asian |
7.003100E-03 |
| Caucasian-vs-AfricanAmerican |
2.532600E-01 |
| Caucasian-vs-Asian |
6.673400E-01 |
| AfricanAmerican-vs-Asian |
2.076600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.178640E-04 |
| Normal-vs-Female |
1.90020000001567E-06 |
| Male-vs-Female |
9.297000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.23860000326104E-08 |
| Normal-vs-Age(41-60Yrs) |
1.67655999999683E-05 |
| Normal-vs-Age(61-80Yrs) |
1.073440E-01 |
| Normal-vs-Age(81-100Yrs) |
9.465800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.600760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.242490E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.294300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.380100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.567430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.801200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.455900E-02 |
| Classical-VS-Follicular |
5.72729641490355E-11 |
| Classical-VS-Other |
6.421800E-01 |
| Classical-VS-Normal |
2.90449997386588E-09 |
| Tall-VS-Follicular |
3.02610000391113E-08 |
| Tall-VS-Other |
5.247000E-01 |
| Tall-VS-Normal |
5.71660000447949E-08 |
| Follicular-VS-Other |
1.844150E-02 |
| Follicular-VS-Normal |
3.613600E-01 |
| Other-VS-Normal |
1.148810E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.155500E-02 |
| Normal-vs-N1 |
3.581400E-04 |
| N0-vs-N1 |
3.239900E-02 |
|
|
